Shopping Cart 0
Cart Subtotal
AED 0

Insmed Inc (INSM) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376

Details

Insmed Inc (INSM)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Insmed Inc (Insmed) is a biopharmaceutical company that focuses on developing novel therapeutics for rare diseases. Its lead product candidate, Arikayce (liposomal amikacin for inhalation), is indicated for the treatment of Nontuberculous mycobacteria (NTM) lung disease in adult patients. Its other clinical pipeline includes INS1007, an orally administered reversible inhibitor of dipeptidyl peptidase 1 (DPP1) for treating non-cystic fibrosis (non-CF) bronchiectasis; INS1009, an inhaled formulation of a treprostinil prodrug which is being developed for pulmonary arterial hypertension (PAH), severe refractory asthma, and other respiratory disorders. . The company operates in the US, the UK, the Netherlands, Ireland, Germany, France, Bermuda and Japan. The company markets it approved product Arikayce in the US. Insmed is headquartered in Bridgewater, New Jersey, the US.

Insmed Inc Key Recent Developments

Aug 01,2019: Insmed reports second quarter 2019 financial results and provides business update

May 07,2019: Insmed reports first quarter 2019 financial results and provides business update

Mar 27,2019: Insmed announces management changes

Feb 22,2019: Insmed reports fourth quarter and full year 2018 financial results and provides business update

Jan 09,2019: Insmed: departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Insmed Inc-Key Facts

Insmed Inc-Key Employees

Insmed Inc-Key Employee Biographies

Insmed Inc-Major Products and Services

Insmed Inc-History

Insmed Inc-Company Statement

Insmed Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Insmed Inc-Business Description

Insmed Inc-Corporate Strategy

Insmed Inc-SWOT Analysis

SWOT Analysis-Overview

Insmed Inc-Strengths

Insmed Inc-Weaknesses

Insmed Inc-Opportunities

Insmed Inc-Threats

Insmed Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Insmed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Insmed Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Insmed Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Aug 01, 2019: Insmed reports second quarter 2019 financial results and provides business update

May 07, 2019: Insmed reports first quarter 2019 financial results and provides business update

Mar 27, 2019: Insmed announces management changes

Feb 22, 2019: Insmed reports fourth quarter and full year 2018 financial results and provides business update

Jan 09, 2019: Insmed: departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers

Nov 09, 2018: Therapure Announces FDA Approval for Manufacturing Insmed's ARIKAYCE

Nov 08, 2018: Insmed announces changes to its Board of Directors

Nov 06, 2018: Insmed to present at three November conferences

Oct 30, 2018: Insmed reports third quarter 2018 financial results and provides business update

Aug 02, 2018: Insmed reports second quarter 2018 financial Results and provides business update

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Insmed Inc, Performance Chart (2014-2018)

Insmed Inc, Ratio Charts

Insmed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Insmed Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Insmed Inc, Key Facts

Insmed Inc, Key Employees

Insmed Inc, Key Employee Biographies

Insmed Inc, Major Products and Services

Insmed Inc, History

Insmed Inc, Subsidiaries

Insmed Inc, Key Competitors

Insmed Inc, Ratios based on current share price

Insmed Inc, Annual Ratios

Insmed Inc, Annual Ratios (Cont...1)

Insmed Inc, Interim Ratios

Insmed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Insmed Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Insmed Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Insmed Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Vertex Pharmaceuticals Inc

Teva Pharmaceuticals USA Inc

Laurent Pharmaceuticals Inc

Gilead Sciences Inc

ContraFect Corp

Chiesi SA

Alfresa Pharma Corp

Company Profile

Company Profile Title

Insmed Inc (INSM)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Insmed Inc (Insmed) is a biopharmaceutical company that focuses on developing novel therapeutics for rare diseases. Its lead product candidate, Arikayce (liposomal amikacin for inhalation), is indicated for the treatment of Nontuberculous mycobacteria (NTM) lung disease in adult patients. Its other clinical pipeline includes INS1007, an orally administered reversible inhibitor of dipeptidyl peptidase 1 (DPP1) for treating non-cystic fibrosis (non-CF) bronchiectasis; INS1009, an inhaled formulation of a treprostinil prodrug which is being developed for pulmonary arterial hypertension (PAH), severe refractory asthma, and other respiratory disorders. . The company operates in the US, the UK, the Netherlands, Ireland, Germany, France, Bermuda and Japan. The company markets it approved product Arikayce in the US. Insmed is headquartered in Bridgewater, New Jersey, the US.

Insmed Inc Key Recent Developments

Aug 01,2019: Insmed reports second quarter 2019 financial results and provides business update

May 07,2019: Insmed reports first quarter 2019 financial results and provides business update

Mar 27,2019: Insmed announces management changes

Feb 22,2019: Insmed reports fourth quarter and full year 2018 financial results and provides business update

Jan 09,2019: Insmed: departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Insmed Inc-Key Facts

Insmed Inc-Key Employees

Insmed Inc-Key Employee Biographies

Insmed Inc-Major Products and Services

Insmed Inc-History

Insmed Inc-Company Statement

Insmed Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Insmed Inc-Business Description

Insmed Inc-Corporate Strategy

Insmed Inc-SWOT Analysis

SWOT Analysis-Overview

Insmed Inc-Strengths

Insmed Inc-Weaknesses

Insmed Inc-Opportunities

Insmed Inc-Threats

Insmed Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Insmed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Insmed Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Insmed Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Aug 01, 2019: Insmed reports second quarter 2019 financial results and provides business update

May 07, 2019: Insmed reports first quarter 2019 financial results and provides business update

Mar 27, 2019: Insmed announces management changes

Feb 22, 2019: Insmed reports fourth quarter and full year 2018 financial results and provides business update

Jan 09, 2019: Insmed: departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers

Nov 09, 2018: Therapure Announces FDA Approval for Manufacturing Insmed's ARIKAYCE

Nov 08, 2018: Insmed announces changes to its Board of Directors

Nov 06, 2018: Insmed to present at three November conferences

Oct 30, 2018: Insmed reports third quarter 2018 financial results and provides business update

Aug 02, 2018: Insmed reports second quarter 2018 financial Results and provides business update

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Insmed Inc, Performance Chart (2014-2018)

Insmed Inc, Ratio Charts

Insmed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Insmed Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Insmed Inc, Key Facts

Insmed Inc, Key Employees

Insmed Inc, Key Employee Biographies

Insmed Inc, Major Products and Services

Insmed Inc, History

Insmed Inc, Subsidiaries

Insmed Inc, Key Competitors

Insmed Inc, Ratios based on current share price

Insmed Inc, Annual Ratios

Insmed Inc, Annual Ratios (Cont...1)

Insmed Inc, Interim Ratios

Insmed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Insmed Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Insmed Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Insmed Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Vertex Pharmaceuticals Inc

Teva Pharmaceuticals USA Inc

Laurent Pharmaceuticals Inc

Gilead Sciences Inc

ContraFect Corp

Chiesi SA

Alfresa Pharma Corp